Allogeneic HSCT for Autoimmune Diseases: A Retrospective Study From the EBMT ADWP, IEWP, and PDWP Working Parties

GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study

(2019) Francesca Bonifazi et al.   Lancet Haematology

The EBMT activity survey report 2017: a focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies

(2019) Jakob R. Passweg et al.   BONE MARROW TRANSPLANTATION

Indications for haematopoietic stem cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2019

(2019) Rafael F. Duarte et al.   BONE MARROW TRANSPLANTATION

Hematopoietic stem cell transplantation in patients with gain-of-function signal transducer and activator of transcription 1 mutations

(2018) Jennifer W. Leiding et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Treatment of severe forms of LPS-responsive beige-like anchor protein deficiency with allogeneic hematopoietic stem cell transplantation

(2018) Markus G. Seidel et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study

(2018) Federica Barzaghi et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT

(2018) Annalisa Ruggeri et al.   Journal of Hematology & Oncology

Unrelated donor vs HLA-haploidentical α/β T-cell– and B-cell–depleted HSCT in children with acute leukemia

(2018) Alice Bertaina et al.   BLOOD

The 2017 IUIS Phenotypic Classification for Primary Immunodeficiencies

(2017) Aziz Bousfiha et al.   JOURNAL OF CLINICAL IMMUNOLOGY

International Union of Immunological Societies: 2017 Primary Immunodeficiency Diseases Committee Report on Inborn Errors of Immunity

(2017) Capucine Picard et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand?

(2017) Alberto Mussetti et al.   Expert Review of Hematology

Long-term outcomes after standard graft-versus-host disease prophylaxis with or without anti-human-T-lymphocyte immunoglobulin in haemopoietic cell transplantation from matched unrelated donors: final results of a randomised controlled trial

(2017) Jürgen Finke et al.   Lancet Haematology

Up-to-date tools for risk assessment before allogeneic hematopoietic cell transplantation

(2016) M Elsawy et al.   BONE MARROW TRANSPLANTATION

Hematopoietic stem cell transplantation for CTLA4 deficiency

(2016) Mary A. Slatter et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants

(2015) J R Passweg et al.   BONE MARROW TRANSPLANTATION

HLA-haploidentical stem cell transplantation after removal of   + T and B cells in children with nonmalignant disorders

(2014) A. Bertaina et al.   BLOOD

SCT for severe autoimmune diseases: consensus guidelines of the European Society for Blood and Marrow Transplantation for immune monitoring and biobanking

(2014) T Alexander et al.   BONE MARROW TRANSPLANTATION

Haploidentical hematopoietic SCT for acquired severe aplastic anemia using post-transplant high-dose CY

(2014) N Gupta et al.   BONE MARROW TRANSPLANTATION

Bone Marrow Transplantation for Acquired Severe Aplastic Anemia

(2014) Andrea Bacigalupo   HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA

Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica

(2013) Raffaella Greco et al.   ANNALS OF NEUROLOGY

Long-Term Outcomes of Hematopoietic Stem Cell Transplantation for Severe Treatment-Resistant Autoimmune Cytopenia in Children

(2012) Marco Rabusin et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan

(2012) M. E. Bernardo et al.   BLOOD

Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation

(2011) J A Snowden et al.   BONE MARROW TRANSPLANTATION

Hematopoietic Stem Cell Transplantation for Multiple Sclerosis: Collaboration of the CIBMTR and EBMT to Facilitate International Clinical Studies

(2010) Marcelo C. Pasquini et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Post-transplantation cyclophosphamide for GVHD prophylaxis in severe aplastic anemia

(2010) A E DeZern et al.   BONE MARROW TRANSPLANTATION

Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation

(2010) Ted A. Gooley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Defining the Intensity of Conditioning Regimens: Working Definitions

(2009) Andrea Bacigalupo et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Hematopoietic Cell Transplantation for Autoimmune Disease: Updates from Europe and the United States

(2009) Keith M. Sullivan et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Allogeneic hematopoietic SCT for patients with autoimmune diseases

(2009) T Daikeler et al.   BONE MARROW TRANSPLANTATION

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

(2008) Leo Luznik et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Will hematopoietic stem cell transplantation cure human autoimmune diseases?

(2008) Alberto M. Marmont   JOURNAL OF AUTOIMMUNITY